Rapid performance increase of RSA drugs requiring system modification
While the industry has had continuous issues about effectiveness of the Risk Sharing Agreement(RSA) System, drugs agreed to the system were observed to be increased in sales.
In an objective perspective about the aggregation, accessibility of pharmaceutical products has actually been improved by...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
